Anzu Partners Launches Third VC Fund for Industrial and Life Science Tech: Report

Anzu Partners

Anzu Partners, an investment firm that focuses on early stage industrial and life science technology companies, has launched its third venture fund with $130 million in commitments to date toward a $300 million target size, Private Equity Wire reports.

Anzu’s Fund III will invest in early-stage breakthrough technology companies that can shape and enable high growth sectors that are essential to prosperity, productivity, and sustainability. The fund’s investors include public and private institutions, single and multifamily offices, and individuals across the U.S. and overseas. Read more.

Total
0
Shares
Related Posts
Read More

Mercy Health Mulling Debt Options

Mercy Health is evaluating its alternatives regarding its existing debt profile, including the potential issuance of new tax-exempt and/or taxable debt to finance or reimburse anticipated or incurred eligible costs in the estimated amount of up to $375 million.